Cefmetazole, flomoxef, and meropenem are effective against planktonic cells but not biofilms of extended-spectrum β-lactamase-producing Escherichia coli

Abstract Background Extended-spectrum β-lactamase (ESBL)-producing Escherichia coli is a potential  public health threat through its spread into the environment. Cefmetazole (CMZ) and flomoxef (FMOX) are highly effective alternatives to meropenem (MEM) for the management of ESBL-producing E. coli in...

Descripció completa

Dades bibliogràfiques

Autors principals:	Nami Hatayama, Yoshinori Sato, Rika Tahira, Toki Hori, Shigeru Tansho-Nagakawa, Yasuo Ono, Yusuke Yoshino
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2025-07-01
Col·lecció:	BMC Microbiology
Matèries:	Extended-spectrum β-lactamase (ESBL)-producing Escherichia coli Biofilms Cefmetazole Flomoxef Meropenem Inhibitory and bactericidal effects of antibiotics
Accés en línia:	https://doi.org/10.1186/s12866-025-04088-z
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!